113 related articles for article (PubMed ID: 38807374)
41. HDAC inhibitor quisinostat prevents estrogen deficiency-induced bone loss by suppressing bone resorption and promoting bone formation in mice.
Sun S; Xiu C; Chai L; Chen X; Zhang L; Liu Q; Chen J; Zhou H
Eur J Pharmacol; 2022 Jul; 927():175073. PubMed ID: 35636521
[TBL] [Abstract][Full Text] [Related]
42. Estrogen Deficiency-Mediated M2 Macrophage Osteoclastogenesis Contributes to M1/M2 Ratio Alteration in Ovariectomized Osteoporotic Mice.
Dou C; Ding N; Zhao C; Hou T; Kang F; Cao Z; Liu C; Bai Y; Dai Q; Ma Q; Luo F; Xu J; Dong S
J Bone Miner Res; 2018 May; 33(5):899-908. PubMed ID: 29281118
[TBL] [Abstract][Full Text] [Related]
43. Resistant dextrin protects against pathological bone loss in ovariectomized rats and inhibits RANKL-induced osteoclastogenesis.
Wang H; Bu X; Chen F; Wang Y; Chen Y
Histol Histopathol; 2022 Nov; 37(11):1127-1141. PubMed ID: 35801271
[TBL] [Abstract][Full Text] [Related]
44. ASPN Synergizes with HAPLN1 to Inhibit the Osteogenic Differentiation of Bone Marrow Mesenchymal Stromal Cells and Extracellular Matrix Mineralization of Osteoblasts.
Zhou G; Yan X; Chen Z; Zeng X; Wu F
Orthop Surg; 2023 Sep; 15(9):2423-2434. PubMed ID: 37427673
[TBL] [Abstract][Full Text] [Related]
45. Ovariectomy-induced bone loss in
Zhu S; He H; Gao C; Luo G; Xie Y; Wang H; Tian L; Chen X; Yu X; He C
J Mol Endocrinol; 2018 Apr; 60(3):185-198. PubMed ID: 29339399
[TBL] [Abstract][Full Text] [Related]
46. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.
Sun D; Krishnan A; Zaman K; Lawrence R; Bhattacharya A; Fernandes G
J Bone Miner Res; 2003 Jul; 18(7):1206-16. PubMed ID: 12854830
[TBL] [Abstract][Full Text] [Related]
47. Protaetia brevitarsis seulensis larvae ethanol extract inhibits RANKL-stimulated osteoclastogenesis and ameliorates bone loss in ovariectomized mice.
Choi RY; Kim IW; Ji M; Paik MJ; Ban EJ; Lee JH; Hwang JS; Kweon H; Seo M
Biomed Pharmacother; 2023 Sep; 165():115112. PubMed ID: 37413903
[TBL] [Abstract][Full Text] [Related]
48. Eicosapentaenoic acid supplementation modulates the osteoblast/osteoclast balance in inflammatory environments and protects against estrogen deficiency-induced bone loss in mice.
Wang Z; Wu J; Li L; Wang K; Wu X; Chen H; Shi J; Zhou C; Zhang W; Hang K; Xue D; Pan Z
Clin Nutr; 2023 Sep; 42(9):1715-1727. PubMed ID: 37542949
[TBL] [Abstract][Full Text] [Related]
49. Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation.
Guo W; Li H; Lou Y; Zhang Y; Wang J; Qian M; Wei H; Xiao J; Xu Y
J Orthop Translat; 2021 May; 28():148-158. PubMed ID: 33981577
[TBL] [Abstract][Full Text] [Related]
50. A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-
Wong P; Lv Z; Li J; Wei Q; Xu L; Fang B; Luo Y; He M
Oxid Med Cell Longev; 2022; 2022():5982014. PubMed ID: 36388169
[TBL] [Abstract][Full Text] [Related]
51. Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways.
Wang T; Liu Q; Zhou L; Yuan JB; Lin X; Zeng R; Liang X; Zhao J; Xu J
Int J Mol Sci; 2015 Nov; 16(11):27470-81. PubMed ID: 26593901
[TBL] [Abstract][Full Text] [Related]
52. The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration.
Mao L; Xia L; Chang J; Liu J; Jiang L; Wu C; Fang B
Acta Biomater; 2017 Oct; 61():217-232. PubMed ID: 28807800
[TBL] [Abstract][Full Text] [Related]
53. A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species.
Hong G; Chen Z; Han X; Zhou L; Pang F; Wu R; Shen Y; He X; Hong Z; Li Z; He W; Wei Q
Clin Transl Med; 2021 May; 11(5):e392. PubMed ID: 34047464
[TBL] [Abstract][Full Text] [Related]
54. Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway.
Zhang Q; Hu S; He Y; Song Z; Shen Y; Zhao Z; Zhang Q; Qin L; Zhang Q
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235631
[TBL] [Abstract][Full Text] [Related]
55. Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome.
Xu L; Zhang L; Wang Z; Li C; Li S; Li L; Fan Q; Zheng L
Calcif Tissue Int; 2018 Oct; 103(4):400-410. PubMed ID: 29804160
[TBL] [Abstract][Full Text] [Related]
56. Genistein and Silicon Synergistically Protects Against Ovariectomy-Induced Bone Loss Through Upregulating OPG/RANKL Ratio.
Chen C; Zheng H; Qi S
Biol Trace Elem Res; 2019 Apr; 188(2):441-450. PubMed ID: 30014283
[TBL] [Abstract][Full Text] [Related]
57. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
58. Avicularin Alleviates Osteoporosis in Ovariectomized Mice by Inhibiting Osteoclastogenesis through NF-κB Pathway Inhibition.
Zhuang Q; Chen S; Zhang W; Gu M; Xiao L; Li Y; Yang Y; Feng C; Li H; Geng D; Wang Z
J Agric Food Chem; 2023 Jan; 71(1):411-420. PubMed ID: 36540936
[TBL] [Abstract][Full Text] [Related]
59. Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.
Cheng J; Zhou L; Liu Q; Tickner J; Tan Z; Li X; Liu M; Lin X; Wang T; Pavlos NJ; Zhao J; Xu J
J Cell Physiol; 2018 Mar; 233(3):2502-2512. PubMed ID: 28771720
[TBL] [Abstract][Full Text] [Related]
60. SHIP1 Activator AQX-1125 Regulates Osteogenesis and Osteoclastogenesis Through PI3K/Akt and NF-κb Signaling.
Xie X; Hu L; Mi B; Panayi AC; Xue H; Hu Y; Liu G; Chen L; Yan C; Zha K; Lin Z; Zhou W; Gao F; Liu G
Front Cell Dev Biol; 2022; 10():826023. PubMed ID: 35445030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
